ras p21表达与DNA倍体、s期分数及结直肠癌预后的关系

Xiao-Feng Sun , Sten Wingren , John M. Carstensen , Olle Stål , Thomas Hatschek , Bernt Boeryd , Bo Nordenskjöld , Hong Zhang
{"title":"ras p21表达与DNA倍体、s期分数及结直肠癌预后的关系","authors":"Xiao-Feng Sun ,&nbsp;Sten Wingren ,&nbsp;John M. Carstensen ,&nbsp;Olle Stål ,&nbsp;Thomas Hatschek ,&nbsp;Bernt Boeryd ,&nbsp;Bo Nordenskjöld ,&nbsp;Hong Zhang","doi":"10.1016/0277-5379(91)90437-I","DOIUrl":null,"url":null,"abstract":"<div><p><em>ras</em> p21 expression, as indicated by the monoclonal antibody ras 11, was estimated using immunohistochemistry on 69 primary colorectal adenocarcinomas. Also, DNA ploidy and S-phase fraction (SPF) were analysed with flow cytometry. Positive staining for ras 11 tended to be more common in DNA non-diploid tumours (<em>P</em> = 0.11), but was significantly correlated with high SPF (<em>P</em> = 0.038). Positive ras 11 staining, Dukes' stage, DNA ploidy and SPF were related to the recurrence-free interval of patients with Dukes' A–C tumours (<em>P</em> = 0.0014, <em>P</em> = 0.023, <em>P</em> = 0.035 and <em>P</em> = 0.040, respectively). ras 11 staining was a prognostic factor independent of both Dukes' stage and DNA ploidy (<em>P</em> = 0.011). The results indicate that pan <em>ras</em> p21 expression is associated with proliferative activity and has an independent prognostic value in colorectal adenocarcinoma.</p></div>","PeriodicalId":11925,"journal":{"name":"European Journal of Cancer and Clinical Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1991-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0277-5379(91)90437-I","citationCount":"16","resultStr":"{\"title\":\"ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma\",\"authors\":\"Xiao-Feng Sun ,&nbsp;Sten Wingren ,&nbsp;John M. Carstensen ,&nbsp;Olle Stål ,&nbsp;Thomas Hatschek ,&nbsp;Bernt Boeryd ,&nbsp;Bo Nordenskjöld ,&nbsp;Hong Zhang\",\"doi\":\"10.1016/0277-5379(91)90437-I\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><em>ras</em> p21 expression, as indicated by the monoclonal antibody ras 11, was estimated using immunohistochemistry on 69 primary colorectal adenocarcinomas. Also, DNA ploidy and S-phase fraction (SPF) were analysed with flow cytometry. Positive staining for ras 11 tended to be more common in DNA non-diploid tumours (<em>P</em> = 0.11), but was significantly correlated with high SPF (<em>P</em> = 0.038). Positive ras 11 staining, Dukes' stage, DNA ploidy and SPF were related to the recurrence-free interval of patients with Dukes' A–C tumours (<em>P</em> = 0.0014, <em>P</em> = 0.023, <em>P</em> = 0.035 and <em>P</em> = 0.040, respectively). ras 11 staining was a prognostic factor independent of both Dukes' stage and DNA ploidy (<em>P</em> = 0.011). The results indicate that pan <em>ras</em> p21 expression is associated with proliferative activity and has an independent prognostic value in colorectal adenocarcinoma.</p></div>\",\"PeriodicalId\":11925,\"journal\":{\"name\":\"European Journal of Cancer and Clinical Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0277-5379(91)90437-I\",\"citationCount\":\"16\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer and Clinical Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/027753799190437I\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer and Clinical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/027753799190437I","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16

摘要

通过单克隆抗体Ras 11,利用免疫组化技术估计了69例原发性结直肠癌中Ras p21的表达。流式细胞术检测DNA倍性和s期分数(SPF)。ras 11阳性染色在DNA非二倍体肿瘤中更为常见(P = 0.11),但与高SPF值显著相关(P = 0.038)。ras 11阳性染色、Dukes分期、DNA倍性和SPF值与Dukes A-C肿瘤无复发间隔相关(P = 0.0014、P = 0.023、P = 0.035、P = 0.040)。ras 11染色与Dukes分期和DNA倍性无关(P = 0.011)。结果表明,pan ras p21的表达与结直肠癌的增殖活性相关,且在结直肠癌中具有独立的预后价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma

ras p21 expression, as indicated by the monoclonal antibody ras 11, was estimated using immunohistochemistry on 69 primary colorectal adenocarcinomas. Also, DNA ploidy and S-phase fraction (SPF) were analysed with flow cytometry. Positive staining for ras 11 tended to be more common in DNA non-diploid tumours (P = 0.11), but was significantly correlated with high SPF (P = 0.038). Positive ras 11 staining, Dukes' stage, DNA ploidy and SPF were related to the recurrence-free interval of patients with Dukes' A–C tumours (P = 0.0014, P = 0.023, P = 0.035 and P = 0.040, respectively). ras 11 staining was a prognostic factor independent of both Dukes' stage and DNA ploidy (P = 0.011). The results indicate that pan ras p21 expression is associated with proliferative activity and has an independent prognostic value in colorectal adenocarcinoma.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信